Liao Ziyue, Tang Cuiping, Luo Rui, Gu Xiling, Zhou Jun, Gao Jian
Department of Gastroenterology and Hepatology, The Second Affiliated Hospital of Chongqing Medical University, No. 76 Linjiang Road, Yuzhong District, Chongqing 400010, China.
Department of Pathology, The Second Affiliated Hospital of Chongqing Medical University, No. 76 Linjiang Road, Yuzhong District, Chongqing 400010, China.
Diagnostics (Basel). 2023 Mar 23;13(7):1211. doi: 10.3390/diagnostics13071211.
The most common cause of hepatocellular carcinoma (HCC) is chronic hepatitis and cirrhosis. It is proposed that precancerous lesions of HCC include all stages of the disease, from dysplastic foci (DF), and dysplastic nodule (DN), to early HCC (eHCC) and progressed HCC (pHCC), which is a complex multi-step process. Accurately identifying precancerous hepatocellular lesions can significantly impact the early detection and treatment of HCC. The changes in high-grade dysplastic nodules (HGDN) were similar to those seen in HCC, and the risk of malignant transformation significantly increased. Nevertheless, it is challenging to diagnose precancerous lesions of HCC. We integrated the literature and combined imaging, pathology, laboratory, and other relevant examinations to improve the accuracy of the diagnosis of precancerous lesions.
肝细胞癌(HCC)最常见的病因是慢性肝炎和肝硬化。有人提出,HCC的癌前病变包括疾病的各个阶段,从发育异常灶(DF)、发育异常结节(DN)到早期HCC(eHCC)和进展期HCC(pHCC),这是一个复杂的多步骤过程。准确识别癌前肝细胞病变对HCC的早期检测和治疗具有重大影响。高级别发育异常结节(HGDN)的变化与HCC相似,恶性转化风险显著增加。然而,诊断HCC的癌前病变具有挑战性。我们综合文献并结合影像学、病理学、实验室及其他相关检查,以提高癌前病变诊断的准确性。